X11a impairs c- but not b-cleavage of amyloid precursor protein
نویسندگان
چکیده
The phosphotyrosine binding domain of the neuronal protein X11a/mint-1 binds to the C-terminus of amyloid precursor protein (APP) and inhibits catabolism to b-amyloid (Ab), but the mechanism of this effect is unclear. Coexpression of X11a or its PTB domain with APPswe inhibited secretion of Ab40 but not APPsbswe, suggesting inhibition of cbut not b-secretase. To further probe cleavage(s) inhibited by X11a, we coexpressed b-secretase (BACE-1) or a component of the c-secretase complex (PS-1D9) with APP, APPswe, or C99, with and without X11a, in HEK293 cells. X11a suppressed the PS-1D9-induced increase in Ab42 secretion generated from APPswe or C99. However, X11a did not impair BACE-1-mediated proteolysis of APP or APPswe to C99. In contrast to impaired c-cleavage of APPswe, X11a or its PTB domain did not inhibit c-cleavage of NotchDE to NICD (the Notch intracellular domain). The X11a PDZ–PS.1D9 interaction did not affect c-cleavage activity. In a cell-free system, X11a did not inhibit the catabolism of APP C-terminal fragments. These data suggest that X11a may inhibit Ab secretion from APP by impairing its trafficking to sites of active c-secretase complexes. By specifically targeting substrate instead of enzyme X11a may function as a relatively specific c-secretase inhibitor.
منابع مشابه
Minocycline blocks c-terminal fragments of amyloid precursor protein-induced neurotoxicity by inhibition of cytochrome c release and caspase-12 activation
Minocycline is a second-generation tetracycline that effectively crosses the blood-brain barrier. It has remarkable neuroprotective qualities in models of cerebral ischaemia, traumatic brain injury, Huntington’s and Parkinson’s diseases. However, there is no evidence about neuroprotective effects of minocycline on AD. Alzheimer’s disease (AD) is a neurodegenerative disorder characterized neurop...
متن کاملMinocycline blocks c-terminal fragments of amyloid precursor protein-induced neurotoxicity by inhibition of cytochrome c release and caspase-12 activation
Minocycline is a second-generation tetracycline that effectively crosses the blood-brain barrier. It has remarkable neuroprotective qualities in models of cerebral ischaemia, traumatic brain injury, Huntington’s and Parkinson’s diseases. However, there is no evidence about neuroprotective effects of minocycline on AD. Alzheimer’s disease (AD) is a neurodegenerative disorder characterized neurop...
متن کاملIndependent Relationship between Amyloid Precursor Protein (APP) Dimerization and γ-Secretase Processivity
Altered production of β-amyloid (Aβ) from the amyloid precursor protein (APP) is closely associated with Alzheimer's disease (AD). APP has a number of homo- and hetero-dimerizing domains, and studies have suggested that dimerization of β-secretase derived APP carboxyl terminal fragment (CTFβ, C99) impairs processive cleavage by γ-secretase increasing production of long Aβs (e.g., Aβ1-42, 43). O...
متن کاملγ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP)
The relative increase in Aβ42 peptides from familial Alzheimer disease (FAD) linked APP and PSEN mutations can be related to changes in both ε-cleavage site utilization and subsequent step-wise cleavage. Cleavage at the ε-site releases the amyloid precursor protein (APP) intracellular domain (AICD), and perturbations in the position of ε-cleavage are closely associated with changes in the profi...
متن کاملAmyloid Precursor Protein and Amyloid b Peptide in Human Platelets
The main component of Alzheimer’s disease (AD) senile plaques is amyloid-b peptide (Ab), a proteolytic fragment of the amyloid precursor protein (APP). Platelets contain both APP and Ab and may contribute to the perivascular amyloid deposition seen in AD. However, no data are available concerning the biochemical mechanism(s) involved in their formation and release by these cells. We found that ...
متن کامل